VOLUME
65 2004 NUMBER 7
CME Pretest 893
CME Posttest 1024
Publisher's Note
896 Stability in a Time of Uncertainty.
[PDF]
Editorial
898 Prepubertal Bipolar I Disorder and Bipolar Disorder NOS
Are Separable From ADHD. Robert M. Post, Kiki D. Chang, Robert
L. Findling, Barbara Geller, Robert A. Kowatch, Stanley P.
Kutcher, and Gabriele S. Leverich
[PDF]
Brainstorms
894 Mechanism of Action of Voltage Sensitive Sodium Channel
Modulators. Stephen M. Stahl
[PDF]
Original Articles
903 A Preliminary, Randomized Trial of Fluoxetine, Olanzapine,
and the Olanzapine-Fluoxetine Combination in Women With
Borderline Personality Disorder. Mary C. Zanarini, Frances R.
Frankenburg, and Elizabeth A. Parachini
[Abstract]
[PDF]
908 Relationships of Age at Onset With Clinical Features and
Cognitive Functions in a Sample of Schizophrenia Patients. Silvio
Bellino, Paola Rocca, Luca Patria, Livio Marchiaro, Roberta
Rasetti, Rossella Di Lorenzo, Erika Paradiso, and Filippo Bogetto
[Abstract]
[PDF]
915 Paroxetine, Other Antidepressants, and Youth Suicide in
New York City: 1993 Through 1998. Andrew C. Leon, Peter M.
Marzuk, Kenneth Tardiff, and Jedediah J. Teres
[Abstract]
[PDF]
919 Neurosyphilis in Newly Admitted Psychiatric Patients:
Three Case Reports. Susan Saik, John E. Kraus, Alex McDonald,
Scott G. Mann, and Brian B. Sheitman
[Abstract]
[PDF]
922 Cognitive-Behavioral Therapy for Medication Nonresponders
With Obsessive-Compulsive Disorder: A Wait-List,Controlled Open
Trial. David F. Tolin, Nicholas Maltby, Gretchen J.
Diefenbach, Scott E. Hannan, and Patrick Worhunsky
[Abstract]
[PDF]
932 Quality of Life in Schizophrenia: The Impact of
Psychopathology, Attitude Toward Medication, and Side Effects. Alex
Hofer, Georg Kemmler, Ursula Eder, Monika Edlinger, Martina
Hummer, and W. Wolfgang Fleischhacker
[Abstract]
[PDF]
940 Changes in Serum Interleukin-2, -6, and -8 Levels Before
and During Treatment With Risperidone and Haloperidol:
Relationship to Outcome in Schizophrenia. Xiang Yang Zhang,
Dong Feng Zhou, Lian Yuan Cao, Pei Yan Zhang, Gui Ying Wu, and Yu
Cun Shen
[Abstract]
[PDF]
948 Prevalence, Correlates, and Disability of Personality
Disorders in the United States: Results From the National
Epidemiologic Survey on Alcohol and Related Conditions. [CME]
Bridget F. Grant, Deborah S. Hasin, Frederick S. Stinson,
Deborah A. Dawson, S. Patricia Chou, W. June Ruan, and Roger P.
Pickering
[Abstract]
[PDF]
959 Incidence and Duration of Side Effects and Those Rated as
Bothersome With Selective Serotonin Reuptake Inhibitor Treatment
for Depression: Patient Report Versus Physician Estimate. X.
Henry Hu, Scott A. Bull, Enid M. Hunkeler, Eileen Ming, Janelle
Y. Lee, Bruce Fireman, and Leona E. Markson
[Abstract]
[PDF]
966 Are Illness Concepts a Powerful Predictor of Adherence to
Prophylactic Treatment in Bipolar Disorder? Nikolaus
Kleindienst and Waldemar Greil
[Abstract]
[PDF]
975 The Effectiveness of Olanzapine, Risperidone, Quetiapine,
and Ziprasidone as Augmentation Agents in Treatment-Resistant
Major Depressive Disorder. James G. Barbee, Erich J. Conrad,
and Nowal J. Jamhour
[Abstract]
[PDF]
982 Naltrexone in the Treatment of Adolescent Sexual
Offenders. Ralph S. Ryback
[Abstract]
[PDF]
987 Antidepressant-Withdrawal Mania: A Critical Review and
Synthesis of the Literature. Chittaranjan Andrade
[Abstract]
[PDF]
994 Obsessive-Compulsive Spectrum Disorders in Rheumatic Fever
With and Without Sydenham's Chorea. Ana Gabriela Hounie, David
L. Pauls, Marcos Tomanik Mercadante, Maria ConceiÁ"o
Ros·rio-Campos, Roseli Gedanke Shavitt, Maria Alice de Mathis,
Pedro Gomes de Alvarenga, Mariana CTri, and Euripedes
Constantino Miguel
[Abstract]
[PDF]
1000 Alcohol Use Disorder Comorbidity in Eating Disorders: A
Multicenter Study. [CME] Cynthia M. Bulik, Kelly L.
Klump, Laura Thornton, Allan S. Kaplan, Bernie Devlin, Manfred M.
Fichter, Katherine A. Halmi, Michael Strober, D. Blake Woodside,
Scott Crow, James E. Mitchell, Alessandro Rotondo, Mauro Mauri,
Giovanni B. Cassano, Pamela K. Keel, Wade H. Berrettini, and
Walter H. Kaye
[Abstract]
[PDF]
Academic Highlights
1007 Sleepiness Versus Sleeplessness: Shift Work and Sleep
Disorders. [CME]
[PDF]
Letters To the Editor
1016 Schizophrenia and Binge-Eating Disorders. Carla E.
Ramacciotti, Riccardo A. Paoli, Mario Catena, Antonio
Ciapparelli, Liliana Dell'Osso, Fiona Schulte, and Paul E.
Garfinkel
[PDF]
1017 The Effects of Newer Antidepressants on Low-Density
Lipoprotein Cholesterol Levels. Jean-Michel Le MellÈdo, Maria
del Pilar Castillo Abadia, Steve Newman, Darrin Bailey, Ross
Tsuyuki, and Gabor Gyenes
[PDF]
- Reply by Linda M. Nicholas, Amy L. Ford, Sharon M. Esposito, R. David Ekstrom, and Robert N. Golden
1018 Duloxetine's Role in the Treatment of Depression and
Associated Painful Physical Symptoms. Madelaine M. Wohlreich,
John G. Watkin, and Jill S. Gonzales
[PDF]
1019 Metyrapone for Delirium Due to Cushing's Syndrome Induced
by Occult Ectopic Adrenocorticotropic Hormone Secretion. Toshiro
Kawashima, Mariko Oda, Taisuke Kuno, Hiroshi Ueki, Shigeto
Yamada, and Akitaka Hisatomi
[PDF]
1020 Beneficial Effects of Gonadotropin-Releasing Hormone
Analogue Treatment on Positive and Negative Symptoms of
Schizophrenia: A Case Report. Noam Soreni, Abraham Weizman,
and Mordechai Weiss
[PDF]
Book Reviews 1022
NOW@Psychiatrist.com 1027
Information for authors
see www.psychiatrist.com/author.htm
for complete information